An experimental drug that can virtually halt the deadly spread of breast cancer has been tested by scientists.
Researchers are now working with a biotechnology company to prepare the compound for patient trials.
The new research builds on previous studies of a gene called Bc13 that appears to play a critical role in the spread of breast cancer.
Scientists at Cardiff University conducted computer simulations to work out how Bc13 functioned and then blocked it.
In tests on mice, the researchers first deleted the gene and then explored ways of inhibiting it with a drug.They found the right candidate compound by screening a library of chemicals until one was found that could target Bc13.
When mice with metastatic breast cancer were treated with the compound, the spread of tumours to the lungs and other parts of the body was dramatically reduced.
More top news
A grandmother says she was outraged after her grandson was segregated from his classmates by a cardboard screen - for being one minute late.
Leaked documents have revealed the first known picture of Mohammed Emwazi - named as IS militant Jihadi John - as a student in London.
With March just around the corner it's looking like this winter will be the sunniest on record (data goes back to 1929).